Anti-coagulant protein triabin containing tyrosine sulfation modification and semi-chemical synthesis method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SOUTH CHINA UNIV OF TECH
- Filing Date
- 2026-04-28
- Publication Date
- 2026-05-29
AI Technical Summary
Existing technologies make it difficult to efficiently prepare Triabin protein with uniform tyrosine sulfate modification through chemical synthesis, which limits its development in anticoagulant activity research and clinical application.
Triabin was synthesized by using Fmoc peptide solid-phase synthesis and E. coli recombinant expression technology to divide it into two fragments. Fragment 1 and fragment 2 were synthesized and purified respectively. The tyrosine-sulfated modified Triabin was synthesized through natural chemical linkage and refolding reaction.
This study improved the synthesis efficiency and stability of tyrosine-sulfated Triabin protein, enhanced its anticoagulant activity, provided a homogenized preparation method, and laid the foundation for the development of clinical anticoagulant drugs.
Smart Images

Figure CN122103315A_ABST
Abstract
Citation Information
Patent Citations
Tyrosine-containing sulfation modified polypeptide synthesis method and application thereof
CN110590911A
Novel thrombin inhibitors
CN113248599A
Chemical synthesis method of hirudin with tyrosine sulfation modification
CN114736289A
Selenocysteine-mediated polypeptide fragment connection method and application thereof in polypeptide / protein synthesis
CN117986318A
Thrombin inhibitor from the saliva of protostomia
US5876971A